News & Updates

Individuals who regularly consume high-fat dairy are at greater risk of death due to chronic liver diseases (CLD), reveals a recent study. However, low-fat dairy intake may lower such risk.

Vitamin D3 may help extend a person’s life expectancy, suggests a study, which notes a decrease in telomere attrition by 140 base pairs with 4 years of supplementation.

The BTK inhibitor rilzabrutinib helps lower disease activity in patients with chronic spontaneous urticaria (CSU) refractory to H1-antihistamines, while having an acceptable adverse event (AE) profile, according to the results of the phase II RILECSU study.

Using beta-blockers early can prevent 1-year mortality in patients with acute myocardial injury (AMI), reveals a recent study.

Adding the novel CD40L inhibitor dapirolizumab pegol (DZP) to standard of care appears to help patients with systemic lupus erythematosus (SLE) achieve low disease activity and remission, according to a prespecified secondary outcome analysis of the phase III PHOENYCS GO trial.

Induction treatment with the anti-TL1A monoclonal antibody tulisokibart appears to produce response in patients with moderately to severely active Crohn’s disease (CD) while being well tolerated, according to the results of a phase IIa trial.